The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kovalenko Yu.A.

Federal state budgetary institution «A.A. Vishnevsky Institute of Surgery», Russian Ministry of Health (director: B.A. Kubyshkin, member of Russian Academy of Sciences]

Zharikov Yu.O.

Institute of Surgery named after A.V. Vishnevskiy, Moscow

Kukeev I.A.

Vishnevsky National Medical Research Center of Surgery of Healthcare Ministry of Russia, Moscow, Russia

Vishnevskiĭ V.A.

FGBU "Institut khirurgii im. A.V. Vishnevskogo" Minzdrava Rossii, Moskva

Chzhao A.V.

FGBU "Institut khirurgii im. A.V. Vishnevskogo" Minzdrava Rossii, Moskva

Predictors of outcomes in surgery for hilar cholangiocarcinoma

Authors:

Kovalenko Yu.A., Zharikov Yu.O., Kukeev I.A., Vishnevskiĭ V.A., Chzhao A.V.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2018;(10): 5‑11

Read: 2146 times


To cite this article:

Kovalenko YuA, Zharikov YuO, Kukeev IA, Vishnevskiĭ VA, Chzhao AV. Predictors of outcomes in surgery for hilar cholangiocarcinoma. Pirogov Russian Journal of Surgery. 2018;(10):5‑11. (In Russ.)
https://doi.org/10.17116/hirurgia20181015

References:

  1. Nuzzo G, Giuliante F, Ardito F, Giovannini I, Aldrighetti L, et al. Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg. 2012;147(1):26-34.
  2. Cho MS, Kim SH, Park SW, Lim JH, Choi GH, Park JS, et al. Surgical outcomes and predicting factors of curative resection in patients with hilar cholangiocarcinoma: 10-year single-institution experience. J Gastrointest Surg. 2012;16(9):1672-1679.
  3. Nimura Y. Radical surgery of left-sided klatskin tumors. HPB (Oxford). 2008;10(3):168-170.
  4. Neuhaus P, Thelen A, Jonas S, Puhl G, Denecke T, et al. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol. 2012;19(5):1602-1608.
  5. Dondero F, Maeda A, Kianmanesh R, Vilgrain V, Belghiti J. Treatment of Cholangiocarcinoma. The Annals of surgical Hepatology. 2003;8(1):47-52. (In Russ.)
  6. Song SC, Choi DW, Kow AW, Choi SH, Heo JS, et al. Surgical outcomes of 230 resected hilar cholangiocarcinoma in a single centre. ANZ J Surg. 2013;83(4):268-274.
  7. Cheng QB, Yi B, Wang JH, Jiang XQ, Luo XJ, et al. Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV. Eur J Surg Oncol. 2012;38(12):1197-1203.
  8. Dinant S, Gerhards MF, Rauws EA, Busch OR, Gouma DJ, van Gulik TM. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol. 2006;13(6):872-880.
  9. Klempnauer J, Ridder GJ, Werner M, Weimann A, Pichlmayr R. What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer. 1997;79(1):26-34.
  10. Li H, Qin Y, Cui Y, Chen H, Hao X, Li Q. Analysis of the surgical outcome and prognostic factors for hilar cholangiocarcinoma: a Chinese experience. Dig Surg. 2011;28(3):226-231.
  11. Dumitrascu T, Chirita D, Ionescu M, Popescu I. Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome. J Gastrointest Surg. 2013;17(5):913-924.
  12. Vishnevsky VA, Efanov MG, Ikramov RZ, Nazarenko NA, Shevchenko TV, Ionkin DA, Zhao AV. Long-term Results after R0 and R1 Resections in Patients with Hilar Cholangiocarcinoma. The Annals of surgical Hepatology. 2013;18(2):9-20. (In Russ.)
  13. Hirano S, Kondo S, Tanaka E, Shichinohe T, Tsuchikawa T, et al. Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. J Hepatobiliary Pancreat Sci. 2010;17(4):455-462.
  14. Wang Y, Yang H, Shen C, Luo J. Surgical procedure and long-term survival of hilar cholangiocarcinoma. Int J Clin Exp Med. 2015;8(1):1122-1128.
  15. Kuang D, Wang GP. Hilar cholangiocarcinoma: pathology and tumor biology. Front Med China. 2010;4(4):371-377.
  16. Nagino M, Ebata T, Yokoyama Y, Igami T, Sugawara G, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013;258(1):129-140.
  17. Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg. 1999;230(6):808-818; discussion 819.
  18. Hasegawa S, Ikai I, Fujii H, Hatano E, Shimahara Y. Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg. 2007;31(6):1256-1263.
  19. Saxena A, Chua TC, Chu FC, Morris DL. Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival. Am J Surg. 2011;202(3):310-320.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.